HM
AKBA icon

HealthCor Management’s Akebia Therapeutics AKBA Stock Holding History

HealthCor Management’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-594,534
Closed -$6.61M – 56
2015
Q1 		$6.61M Sell
594,534
-250,720
-30% -$2.67M 0.32% 53
2014
Q4 		$9.84M Sell
845,254
-54,746
-6% -$785K 0.55% 37
2014
Q3 		$19.9M Hold
900,000
– – 1.02% 30
2014
Q2 		$25M Buy
+900,000
New +$21.7M 1.25% 29

Other funds holding AKBA

EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

HealthCor Management's AKBA Position: Q2 2015 in Review

HealthCor Management sold out of Akebia Therapeutics (AKBA) in Q2 2015, closing a stake of 594,534 shares — an estimated $6.61M sold.

HealthCor Management first reported a position in AKBA in Q2 2014 and held it in 4 quarters. The position peaked at $25M in Q2 2014. 73 funds tracked by Wall St. Rank hold AKBA as of Q2 2015.

  • HealthCor Management reported no remaining Akebia Therapeutics position as of Q2 2015 after selling out during the quarter.
  • HealthCor Management sold 594,534 Akebia Therapeutics shares in Q2 2015, an estimated $6.61M.
  • HealthCor Management first reported a position in Akebia Therapeutics in Q2 2014 and held it in 4 quarters.
  • HealthCor Management's Akebia Therapeutics position peaked at $25M in Q2 2014.
  • 73 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q2 2015.

Based on HealthCor Management's 13F filing for Q2 2015, filed 14 Aug 2015.